1.02
-0.02(-1.92%)
Currency In USD
| Previous Close | 1.04 |
| Open | 1.04 |
| Day High | 1.08 |
| Day Low | 1 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.26 |
| Volume | 886,514 |
| Average Volume | 679,366 |
| Market Cap | 189.41M |
| PE | -4.64 |
| EPS | -0.22 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 1.28 |
| Change | -0.02 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $102.62 as of July 31, 2025 at a share price of $1.02. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $95.24 as of July 31, 2025 at a share price of $1.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
GlobeNewswire Inc.
Yesterday at 4:41 PM GMT
WARREN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the Company’s significant insider ownership of outstanding common stock, as most recently reported on July 10, 2025
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
GlobeNewswire Inc.
Jul 28, 2025 3:52 PM GMT
WARREN, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today welcomes the White House’s release of “Winning the Race: America’s AI Action Plan”, issued July 23, 2025. The Company applauds
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
GlobeNewswire Inc.
Jul 18, 2025 4:36 PM GMT
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international p